combination treatment articles & resources on Made-in-China.com

Packaging Defects Prompted a Recall of a Combination Cholesterol Drug Called Liptruzet

Jan 16, 2014

Packaging defects have prompted a recall of a combination cholesterol drug called Liptruzet, produced by Merck & Co., temporarily affecting the entire U.S. stock. Merck said the foil pouches holding Liptruzet pills could allow air and ...

Tags: recall, Liptruzet, Merck, packaging defects

Packaging Defects Prompted a Recall of a Combination Cholesterol Drug Called Liptruzet

Jan 15, 2014

Packaging defects have prompted a recall of a combination cholesterol drug called Liptruzet, produced by Merck & Co., temporarily affecting the entire U.S. stock. Merck said the foil pouches holding Liptruzet pills could allow air and ...

Tags: Drug, Health, Medicine, Drug Packaging, Packaging

Drugs Mekinist and Tafinlar Were Approved for Combination Treatment of Advanced Melanoma

Jan 13, 2014

The drugs Mekinist and Tafinlar were approved for combination treatment of advanced melanoma skin cancer, the U.S. Food and Drug Administration announced Friday. The two medicines "are the first drugs approved for combination treatment of ...

Tags: FDA, 2-Drug Combo Treatment, Combo Treatment for Advanced Melanoma

FDA Approved Mekinist, or Trametinib, in Combination with Tafinlar

Jan 10, 2014

The U.S. Food and Drug Administration approved Mekinist, or trametinib, in combination with Tafinlar, or dabrafenib, to treat patients with advanced melanoma. Dr. Richard Pazdur, director of the Office of Hematology and Oncology Products ...

Tags: Skin Cancer, Health, Medicine

A New Combination of Drugs Might Prolong Life in Certain Older Leukemia Patients

Jan 10, 2014

A new combination of drugs might prolong life in certain older leukemia patients, a new study suggests. The research, led by German scientists, included nearly 800 older people (average age 73) who had been diagnosed with chronic ...

Tags: Drug, Drug Combo, Leukemia

Two Drugs Might Be Better Than One When It Comes to Helping Hardcore Smokers Quit

Jan 9, 2014

Two drugs in combination might be better than one when it comes to helping hardcore smokers quit, at least in the short term, a new study suggests. The drugs -- varenicline (sold under the brand name Chantix) and bupropion (Wellbutrin) ...

Tags: a

Women with Aggressive Breast Cancer Have a Slightly Improved Chance of Staying Cancer-Free

Dec 27, 2013

Women with aggressive breast cancer who receive combination targeted therapy with chemotherapy prior to surgery have a slightly improved chance of staying cancer-free, researchers say. However, the improvement was not statistically ...

Tags: aggressive breast cancer, targeted therapy with chemotherapy

FDA Has Recommended The Approval of Investigational Copd Drug in US

Sep 13, 2013

The Pulmonary-Allergy Drugs Advisory Committee (PADAC) of the US Food and Drug Administration (FDA) has recommended the approval of GlaxoSmithKline (GSK) and Theravance's umeclidinium/vilanterol as a treatment for chronic obstructive ...

Tags: Health, Medicine, Investigational Copd Drug

Vivus Received Approval From The US FDA for Its Qsymia as an Adjunct to a Diet

Dec 5, 2012

Vivus has received approval from the US Food and Drug Administration (FDA) for its Qsymia as an adjunct to a reduced-calorie diet. Qsymia will be used to manage chronic weight in adult patients with an initial body mass index (BMI) of 30 ...

Tags: reduced-calorie diet, Qsymia, combination treatment

Catalent Has Signed a Supply Agreement with Vivus

Nov 28, 2012

Catalent Pharma Solutions has signed a supply agreement with Vivus to supply Qsymia capsules, a proprietary combination phentermine and extended-release topiramate. Catalent Modified Release Technologies president Ian Muir said Catalent ...

Tags: Qsymia capsules, extended-release topiramate, combination therapy

combination treatment

Related Products